These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

47 related items for PubMed ID: 12730544

  • 1. The prevalence of patients with rheumatoid arthritis in the West Midlands fulfilling the BSR criteria for anti-tumour necrosis factor therapy: an out-patient study.
    Yee CS, Filer A, Pace A, Douglas K, Situnayake D, Rowe IF, West Midlands Rheumatology Services and Training Committee.
    Rheumatology (Oxford); 2003 Jul; 42(7):856-9. PubMed ID: 12730544
    [Abstract] [Full Text] [Related]

  • 2. Racial disparities in treatment preferences for rheumatoid arthritis.
    Constantinescu F, Goucher S, Weinstein A, Fraenkel L.
    Med Care; 2009 Mar; 47(3):350-5. PubMed ID: 19165120
    [Abstract] [Full Text] [Related]

  • 3. Is the treatment of inflammatory arthritis different in sickle cell disease?
    Kimyon G, İlhan G.
    Turk J Med Sci; 2022 Jun; 52(5):1721-1728. PubMed ID: 36422487
    [Abstract] [Full Text] [Related]

  • 4. Compliance with NICE guidance on the use of anti-TNFalpha agents in ankylosing spondylitis: an east and west Midlands regional audit.
    Rees F, Peffers G, Bell C, Obrenovic K, Sandhu R, Packham J, Erb N, West Midlands Regional STC and East Midlands Regional Audit Group.
    Clin Med (Lond); 2012 Aug; 12(4):324-7. PubMed ID: 22930875
    [Abstract] [Full Text] [Related]

  • 5. To what extent is NICE guidance on the management of rheumatoid arthritis in adults being implemented in clinical practice? A regional survey.
    Tugnet N, Pearce F, Tosounidou S, Obrenovic K, Erb N, Packham J, Sandhu R.
    Clin Med (Lond); 2013 Feb; 13(1):42-6. PubMed ID: 23472494
    [Abstract] [Full Text] [Related]

  • 6. An assessment of the current treatment landscape for rheumatology patients in Qatar: Recognising unmet needs and moving towards solutions.
    Emadi SA, Hammoudeh M, Mounir M, Mueller RB, Wells AF, Sarakbi HA.
    J Int Med Res; 2017 Apr; 45(2):733-743. PubMed ID: 28415924
    [Abstract] [Full Text] [Related]

  • 7. Audits of the prevention and treatment of corticosteroid-induced osteoporosis in outpatients with rheumatic diseases in the West Midlands.
    Paskins Z, Potter T, Erb N, Obrenovic K, Rowe IF, West Midlands Rheumatology Services and Training Committee.
    Clin Med (Lond); 2006 Apr; 6(2):183-7. PubMed ID: 16688979
    [Abstract] [Full Text] [Related]

  • 8. Certolizumab pegol (CDP870) for rheumatoid arthritis in adults.
    Ruiz Garcia V, Burls A, Cabello JB, Vela Casasempere P, Bort-Marti S, Bernal JA.
    Cochrane Database Syst Rev; 2017 Sep 08; 9(9):CD007649. PubMed ID: 28884785
    [Abstract] [Full Text] [Related]

  • 9. Rituximab as first choice for patients with refractory rheumatoid arthritis: cost-effectiveness analysis in Iran based on a systematic review and meta-analysis.
    Ahmadiani S, Nikfar S, Karimi S, Jamshidi AR, Akbari-Sari A, Kebriaeezadeh A.
    Rheumatol Int; 2016 Sep 08; 36(9):1291-300. PubMed ID: 27136919
    [Abstract] [Full Text] [Related]

  • 10. Etanercept for the treatment of rheumatoid arthritis.
    Lethaby A, Lopez-Olivo MA, Maxwell L, Burls A, Tugwell P, Wells GA.
    Cochrane Database Syst Rev; 2013 May 31; 2013(5):CD004525. PubMed ID: 23728649
    [Abstract] [Full Text] [Related]

  • 11. Eight years' experience of regional audit: an assessment of its value as a clinical governance tool.
    John H, Paskins Z, Hassell A, Rowe IF, West Midlands Rheumatology Service and Training Committee.
    Clin Med (Lond); 2010 Feb 31; 10(1):20-5. PubMed ID: 20408300
    [Abstract] [Full Text] [Related]

  • 12. Tumor necrosis factor antagonist responsiveness in a United States rheumatoid arthritis cohort.
    Greenberg JD, Kishimoto M, Strand V, Cohen SB, Olenginski TP, Harrington T, Kafka SP, Reed G, Kremer JM, Consortium of Rheumatology Researchers of North America Investigators.
    Am J Med; 2008 Jun 31; 121(6):532-8. PubMed ID: 18501236
    [Abstract] [Full Text] [Related]

  • 13. Tumour necrosis factor blockers do not increase overall tumour risk in patients with rheumatoid arthritis, but may be associated with an increased risk of lymphomas.
    Geborek P, Bladström A, Turesson C, Gulfe A, Petersson IF, Saxne T, Olsson H, Jacobsson LT.
    Ann Rheum Dis; 2005 May 31; 64(5):699-703. PubMed ID: 15695534
    [Abstract] [Full Text] [Related]

  • 14. Infliximab: a pharmacoeconomic review of its use in rheumatoid arthritis.
    Lyseng-Williamson KA, Foster RH.
    Pharmacoeconomics; 2004 May 31; 22(2):107-32. PubMed ID: 14731052
    [Abstract] [Full Text] [Related]

  • 15. The prevalence of patients with rheumatoid arthritis in the West Midlands fulfilling the BSR criteria for anti-tumour necrosis factor therapy: an out-patient study.
    Yee CS, Filer A, Pace A, Douglas K, Situnayake D, Rowe IF, West Midlands Rheumatology Services and Training Committee.
    Rheumatology (Oxford); 2003 Jul 31; 42(7):856-9. PubMed ID: 12730544
    [Abstract] [Full Text] [Related]

  • 16. Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
    Hyrich KL, Watson KD, Silman AJ, Symmons DP, British Society for Rheumatology Biologics Register.
    Rheumatology (Oxford); 2006 Dec 31; 45(12):1558-65. PubMed ID: 16705046
    [Abstract] [Full Text] [Related]

  • 17. The impact of escalating conventional therapy in rheumatoid arthritis patients referred for anti-tumour necrosis factor-alpha therapy.
    Bingham SJ, Buch MH, Tennant A, Emery P.
    Rheumatology (Oxford); 2004 Mar 31; 43(3):364-8. PubMed ID: 14657509
    [Abstract] [Full Text] [Related]

  • 18. Eligibility of patients in routine care for major clinical trials of anti-tumor necrosis factor alpha agents in rheumatoid arthritis.
    Sokka T, Pincus T.
    Arthritis Rheum; 2003 Feb 31; 48(2):313-8. PubMed ID: 12571838
    [Abstract] [Full Text] [Related]

  • 19. Biologics in rheumatoid arthritis.
    Sharma PK, Hota D, Pandhi P.
    J Assoc Physicians India; 2004 Mar 31; 52():231-6. PubMed ID: 15636315
    [Abstract] [Full Text] [Related]

  • 20. [Lesson from ACR guidelines for management of RA].
    Abe T.
    Nihon Rinsho; 2005 Jan 31; 63 Suppl 1():431-8. PubMed ID: 15799394
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.